In-silico Drug Design and in-silico screening

In-silico drug design can take part much in all stages of drug development from the preclinical discovery stage to late stage clinical development.

During the process of selection of novel drug candidates, many essential steps are taken to eliminate such compounds that have side effects and also show interaction with other drugs. In-silico drug designing softwares show an important role to design progressive proteins or drugs in biotechnology or the pharmaceutical field. 

  • Structural Biology
  • Molecular Docking
  • Virtual Screening Methods
  • Computation approaches for fragment based Drug Discovery
  • Intellectual property issues arising from in silico Discovery
  • Enzyme Inhibitors

Related Conference of In-silico Drug Design and in-silico screening

June 08-09, 2018

7th International conference on Pharmaceutical Auditing

Baltimore, Maryland, USA
June 27-28, 2018

4th International Conference on Drug Discovery, Designing and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

3rd International Conference on Generics Drugs and Biosimilars

November 15-17, 2018 | Frankfurt, Germany
October 18-19, 2018

18th World Pharma Congress

Warsaw, Poland
August 15-17, 2018

8th World Congress Spectroscopy and Analytical Techniques

Stockholm, Sweden
September 18-19, 2018

6th European Biopharma Congress

Amsterdam, Netherlands

In-silico Drug Design and in-silico screening Conference Speakers

Recommended Sessions

Related Journals

Are you interested in